Código QR (código de barras bidimensional)

Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study

A better understanding of the long-term safety, efficacy, and immunogenicity of COVID-19 vaccines is needed. This phase 3, randomized, placebo-controlled study for AZD1222 (ChAdOx1 nCoV-19) primary-series vaccination enrolled 32,450 participants in the USA, Chile, and Peru between August 2020 and Ja...

ver descrição completa

Na minha lista:
Principais autores: Kathryn Shoemaker, Karina Soboleva, Angela Branche, Shivanjali Shankaran, Deborah A. Theodore, Muhammad Bari, Victor Ezeh, Justin Green, Elizabeth Kelly, Dongmei Lan, Urban Olsson, Senthilkumar Saminathan, Nirmal Kumar Shankar, Berta Villegas, Tonya Villafana, Ann R. Falsey, Magdalena E. Sobieszczyk
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2024-08-01
coleção:Vaccines
Assuntos:
AZD1222 (ChAdOx1 nCoV-19)
COVID-19
long-term safety
SARS-CoV-2
humoral immunogenicity
COVID-19 vaccine
Acesso em linha:https://www.mdpi.com/2076-393X/12/8/883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados